Aires I. D., Madeira M. H., Boia R., Rodrigues-Neves A. C., Martins J. M., Ambrosio A. F. et al. 2019 Intravitreal injection of adenosine A(2A) receptor antagonist reduces neuroinflammation, vascular leakage and cell death in the retina of diabetic mice. Sci. Rep. 9, 17207.

Article  PubMed  PubMed Central  Google Scholar 

Ding C., Xi G., Wang G., Cui D., Zhang B., Wang H. et al. 2020 Exosomal Circ-MEMO1 promotes the progression and aerobic glycolysis of non-small cell lung cancer through targeting MiR-101-3p/KRAS axis. Front. Genet. 11, 962.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ebneter A. and Zinkernagel M. S. 2016 Novelties in diabetic retinopathy. Endocr. Dev. 31, 84–96.

Article  CAS  PubMed  Google Scholar 

Feng Y., Wang C. and Wang G. 2022 Inhibition of KCTD10 affects diabetic retinopathy progression by reducing VEGF and affecting angiogenesis. Genet. Res. (Camb) 2022, 4112307.

Article  PubMed  Google Scholar 

Fu Y., Wang Y., Gao X., Li H. and Yuan Y. 2020 Dynamic expression of HDAC3 in db/db Mouse RGCs and its relationship with apoptosis and autophagy. J. Diabetes Res. 2020, 6086780.

Article  PubMed  PubMed Central  Google Scholar 

Gong Y., Li X. and Xie L. 2022 Circ_0001897 regulates high glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-29c-3p/transforming growth factor beta 2 axis. Bioengineered 13, 11694–11705.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Q.Y., Lai X.N., Qian X.L., Lv L.C., Li J., Duan J. et al. 2019 Cdc42: A novel regulator of insulin secretion and diabetes-associated diseases. Int. J. Mol. Sci. 20.

Jadeja R. N., Jones M. A., Abdelrahman A. A., Powell F. L., Thounaojam M. C., Gutsaeva D. et al. 2020 Inhibiting microRNA-144 potentiates Nrf2-dependent antioxidant signaling in RPE and protects against oxidative stress-induced outer retinal degeneration. Redox. Biol. 28, 101336.

Article  CAS  PubMed  Google Scholar 

Jenkins A. J., Joglekar M. V., Hardikar A. A., Keech A. C., O’Neal D. N. and Januszewski A. S. 2015 Biomarkers in diabetic retinopathy. Rev. Diabet. Stud. 12, 159–195.

Article  PubMed  PubMed Central  Google Scholar 

Jiang X., Ruan X. L., Xue Y. X., Yang S., Shi M. and Wang L. N. 2020 Metformin reduces the senescence of renal tubular epithelial cells in diabetic nephropathy via the MBNL1/miR-130a-3p/STAT3 pathway. Oxid. Med. Cell Longev. 2020, 8708236.

Article  PubMed  PubMed Central  Google Scholar 

Kim H. J., Jeong M. S. and Jang S. B. 2021 Molecular characteristics of RAGE and advances in small-molecule inhibitors. Int. J. Mol. Sci. 22.

Lechner J., O’Leary O. E. and Stitt A. W. 2017 The pathology associated with diabetic retinopathy. Vision Res. 139, 7–14.

Article  PubMed  Google Scholar 

Lin K. Y., Hsih W. H., Lin Y. B., Wen C. Y. and Chang T. J. 2021 Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J. Diabetes Investig. 12, 1322–1325.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y. and Wu N. 2021 Progress of nanotechnology in diabetic retinopathy treatment. Int. J. Nanomedicine. 16, 1391–1403.

Article  PubMed  PubMed Central  Google Scholar 

Liu Z., Hu L., Zhang T., Xu H., Li H., Yang Z. et al. 2020 PKCbeta increases ROS levels leading to vascular endothelial injury in diabetic foot ulcers. Am. J. Transl. Res. 12, 6409–6421.

CAS  PubMed  PubMed Central  Google Scholar 

Maekawa S., Sato K., Fujita K., Daigaku R., Tawarayama., Murayama N. et al. 2017 The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation. Sci. Rep. 7, 6885.

Article  PubMed  PubMed Central  Google Scholar 

Meng S., Cao J., Zhang X., Fan Y., Fang L., Wang C. et al. 2013 Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One 8, e68611.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Millan I., Desco M. D. C., Torres-Cuevas I., Perez S., Pulido I., Mena-Molla S. et al. 2019 Pterostilbene prevents early diabetic retinopathy alterations in a rabbit experimental model. Nutrients 12.

Moreno A., Lozano M. and Salinas P. 2013 Diabetic retinopathy. Nutr. Hosp. 28(Suppl 2), 53–56.

PubMed  Google Scholar 

Raut S. K., Kumar A., Singh G. B., Nahar U., Sharma V., Mittal A. et al. 2015 miR-30c Mediates upregulation of Cdc42 and Pak1 in diabetic cardiomyopathy. Cardiovasc. Ther. 33, 89–97.

Article  CAS  PubMed  Google Scholar 

Robinson R., Srinivasan M., Shanmugam A., Ward A., Ganapathy V., Bloom J. et al. 2020 Interleukin-6 trans-signaling inhibition prevents oxidative stress in a mouse model of early diabetic retinopathy. Redox Biol. 34, 101574.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santos A. S., Cunha Neto E., Fukui R. T., Ferreira L. R. P. and Silva M. E. R. 2019 Increased expression of circulating microRNA 101–3p in Type 1 diabetes patients: new insights into miRNA-regulated pathophysiological pathways for type 1 diabetes. Front. Immunol. 10, 1637.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smit-McBride Z. and Morse L. S. 2021 MicroRNA and diabetic retinopathy-biomarkers and novel therapeutics. Ann. Transl. Med. 9, 1280.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao F., Yu J., Liu B., Guo Y., Li K., Deng J. et al. 2014 A novel function of microRNA 130a–3p in hepatic insulin sensitivity and liver steatosis. Diabetes 63, 2631–2642.

Article  CAS  PubMed  Google Scholar 

Xiao X. H., Huang Q. Y., Qian X. L., Duan J., Jiao X. Q., Wu L. Y. et al. 2019 Cdc42 Promotes ADSC-derived IPC induction, proliferation, and insulin secretion via Wnt/beta-catenin signaling. Diabetes Metab. Syndr. Obes. 12, 2325–2339.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ye M., Li D., Yang J., Xie J., Yu F., Ma Y. et al. 2015 MicroRNA-130a targets MAP3K12 to modulate diabetic endothelial progenitor cell function. Cell Physiol. Biochem. 36, 712–726.

Article  CAS  PubMed  Google Scholar 

Zhang M., Zhao S., Xu C., Shen Y., Huang J., Shen S. et al. 2020 Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p/TLR4 signaling axis. Biochem. Biophys. Res. Commun. 533, 429–436.

Article  CAS  PubMed  Google Scholar 

Zhao J., Cai C. K., Xie M., Liu J. N. and Wang B. Z. 2018 Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ. J. Ethnopharmacol. 224, 1–14.

Article  CAS  PubMed  Google Scholar